95.77
+3.45
+(3.74%)
At close: April 11 at 9:40:48 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 7 | 7 |
Avg. Estimate | 5.95B | 5.97B | 24.32B | 25.55B |
Low Estimate | 5.74B | 5.72B | 23.16B | 23.61B |
High Estimate | 6.1B | 6.22B | 25.44B | 27.49B |
Year Ago Sales | 6.12B | 6.03B | 23.7B | 24.32B |
Sales Growth (year/est) | -2.81% | -0.84% | 2.63% | 5.04% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EO5.F | -- | -- | -- | -- |
S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
Upgrade | Scotiabank: Sector Perform to Sector Outperform | 4/11/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/27/2025 |
Downgrade | Mizuho: Outperform to Neutral | 3/25/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 3/18/2025 |
Maintains | Citigroup: Neutral to Neutral | 3/17/2025 |
Maintains | JP Morgan: Neutral to Neutral | 3/13/2025 |